References

  1. Walbbmers JM, Jacob MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189(1): 12-19. PubMed | Google Scholar

  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 200 CA Cancer J Clin. 2005; 55(2): 74-108. PubMed | Google Scholar

  3. WHO: International Agency for Research on Cancer. Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. The GLOBOCAN 2012 database. International Agency for Research on Cancer. Accessed February 15, 2014.

  4. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006; 20(2): 207-22. PubMed | Google Scholar

  5. Forman D, de Martel C, Lacey C et al. Global burden of human papillomavirus and related diseases. Vaccines. 2012; 30(Suppl 5): 12-23. PubMed | Google Scholar

  6. Thomas J, Ojemakinde O, Izebraye I. Current concepts in cervical carcinogenesis and new perspectives in prevention. Arch Ibadan Med. 2002; 3(1): 36-9. Google Scholar

  7. WHO: International Agency for Research on Cancer. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide. Accessed February 15, 2014.

  8. Aral SO, Holmes KK. The epidemiology of STIs and their social and behavioural determinants: industrialized and developing countries. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, eds; Sexually Transmitted Diseases. New York: McGraw-Hill. 2008; 4: 53-92. In Press

  9. David JK, Alison NF. Towards prevention of cervical cancer in Africa: report from method at St Catherine College, Oxford. Afrox. 2009: 2-28. In Press

  10. Salazar EL, Mercado E, Calzada L. Human papillomavirus hpv-16 DNA as an epitheliotropic virus that induces hyperproliferation in squamous penile tissue. Arch Androl. 2005; 51(4): 327-34. PubMed | Google Scholar

  11. Lissouba P, Van de Perre P, Aubert B. Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2013; 89(5): 350. PubMed | Google Scholar

  12. Centers for Disease Control and Prevention (CDC). Fact Sheet: Genital HPV Infection. 2008. Accessed 13 November 2009.

  13. Castellsague X, Munoz N. Cofactors in human papillomavirus carcinogenesis: role of parity, oral contraceptives and tobacco smoking. J Nat Cancer Inst Monogr. 2003; 31: 20-8. PubMed | Google Scholar

  14. Koutsky LA, Holmes, KK, Critchlow CW, Stevens CE, Paavonen J, Beckman AM et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. New Eng J Med. 1992; 327(18): 1272-8. PubMed | Google Scholar

  15. Oboma YI, Avwioro GO. Prevalence of cervical human papillomavirus infection among women in Bayelsa state, Nigeria. Cont J Biomed Sci. 2012; 6(1): 1-3. Google Scholar

  16. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the international agency for research on cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005; 366(9490): 991-8. PubMed | Google Scholar

  17. Adegbesan-Omilabu M, Okunade K, Gbadegesin A, Olowoselu O, Oluwole A, Omilabu S. Seroprevalence of hepatitis B virus infection among pregnant women at the antenatal booking clinic of a Tertiary Hospital in Lagos Nigeria. Niger J Clin Pract. 2015; 18(6): 819-23. PubMed | Google Scholar

  18. Charan J and Biswas T. How to Calculate Sample Size for Different Study Designs in Medical Research. Indian J Psychol Med. 2013; 35(2): 121-126. PubMed | Google Scholar

  19. Adegbesan-Omilabu MA, Okunade KS, Omilabu SA. Oncogenic human papillomavirus infection amongst women attending the cytology clinic of a tertiary hospital in Lagos, South-West Nigeria. Int J Res Med Sci. 2014; 2(2): 625-630. Google Scholar

  20. Sanjose de S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX. Worldwide Prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2003; 7(7): 453-9. PubMed | Google Scholar

  21. Pham TH, Nguyen TH, Herrero R, Vaccarella S, Smith JS, Nguyen HN et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer. 2003; 104(2): 213-20. PubMed | Google Scholar

  22. Sukvirach S, Smith JS, Tunsakul S, Munoz N, Kesaravat V, Opasatian O et al. Population-based human papillomavirus in Lampang and Songkla, Thailand. J Infect Dis. 2003; 187(8): 1246-56. PubMed | Google Scholar

  23. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS et al. Prevalence of HPV infection among females in the United States. J Am Med Assoc. 2007; 297(8): 813-9. PubMed | Google Scholar

  24. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer. 2004; 90(3): 638-45. PubMed | Google Scholar

  25. Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria. Int J Cancer. 2012; 130(9): 2111-2117. PubMed | Google Scholar

  26. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I et al. HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer. 2009; 101(1): 202-208. PubMed | Google Scholar

  27. Nweke IG, Banjo AF, Abdulkareem FB, Nwadike VU. Prevalence of human papillomavirus DNA in HIV-positive women in Lagos University Teaching Hospital (LUTH) Lagos, Nigeria. Br Microbiol Res J. 2013; 3(3): 400-13. Google Scholar

  28. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C. Sexual behaviour and smoking as determinants of cervical human papillomavirus infection and of cervical intraepithelial neoplasm CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer. 2000; 83(11): 1565-72. Google Scholar